Approval · Notice of Compliance 22286 · 2019
NERFASIN 100: Notice of Compliance 22286
Issued June 13, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22286
- Date
- June 13, 2019
- Company
- Dechra Regulatory BvBladel, Netherlands
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Changes in product wonership
- Canadian reference product
- ROMPUN (Bayer Inc., Animal Health)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NERFASIN 100 | 02450240 | Marketed |
Medicinal ingredients
- XYLAZINE HCL 100 MG per ML